智翔金泰：10月29日召开董事会会议

Group 1 - The core point of the article is that Zhixiang Jintai (SH 688443) held its second fifth board meeting on October 29, 2025, to discuss the proposal for the first extraordinary general meeting of shareholders in 2025 [1] - Zhixiang Jintai's revenue composition for the year 2024 is reported to be 99.92% from the pharmaceutical manufacturing industry and 0.08% from other businesses [2] - As of the report, Zhixiang Jintai has a market capitalization of 10.9 billion yuan [2]